Patent · US Expired

Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use

US6013620A · kind A · utility

41Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 1997
Grant dateJan 11, 2000
Priority date
Expiry dateSep 11, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/21021
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a pharmaceutical composition for the treatment of patients with blood coagulation diseases which are caused by coagulation factor deficiency and/or inhibitors of coagulation factors, whereby the composition as a FEIB-activity and is characterized in that it has Factor VIIa and at least one further active ingredient and the activity of at least 10 Factor VIIa units per unit FEIBA. Additionally, the invention comprises a method for the production of the pharmaceutical preparation and its use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.